information management services‚ and coding systems. The professional services segment includes implementation services‚ training‚ support services‚ and consulting. Based on the type of buyer‚ the global eClinical solutions market is segmented into pharmaceutical/biopharmaceutical/medical device companies‚ clinical research organizations (CROs)‚ and healthcare providers. Based on the
Premium Clinical trial Clinical research Pharmaceutical industry
Analysis 31 VI. Ranbaxy Financials 32 VII. Pharmaceutical Industry Future 33 VIII. Conservation of energy and its impact 37 Executive Summary Product patent regime implemented in India from Jan 2005 compelled Indian pharma companies to relook in to their marketing strategies so as to become competitive & strongly withstand in the competition with MNC’s & big giants in domestic markets. Product patent regime posed Indian pharmaceutical companies to change their strategies. If the
Premium Generic drug Pharmaceutical industry Ranbaxy Laboratories
Project Corporate finance Project Sun pharmaceuticals Sun pharmaceuticals Submitted to : Prof. S.Ramesh Submitted by : Shamili.M (FPB1214/125) Submitted to : Prof. S.Ramesh Submitted by : Shamili.M (FPB1214/125) Type | Public | Traded as | BSE : 524715 NSE: sunpharma | Industry | Pharmaceuticals | Founded | 1983 | Founder | Dilip
Premium Pharmaceutical industry Pharmacology
Berry Teva Thought Paper Sunday‚ March 1‚ 2015 Israel played a major role in the development of Teva Pharmaceutical Industries. Teva was founded in the early 1900s and continued to rise to become one of the leading companies in the Pharmaceuticals industry. When analyzing porter’s diamond it was clear to me how Israel helped this company develop into what it is today. First off‚ the pharmaceutical industry birthplace was Germany. This being said Teva benefited highly from the trained scientists
Premium Pharmacology Generic drug Pharmaceutical industry
2008‚ from Statistical Thinking for: http://home.ubalt.edu/ntsbarsh/Business-stat/opre504.htm#rwhatbussts Dictionary.com‚ LLC. (2008). Retrieved September 22‚ 2008‚ from Dictionary.com: http://dictionary.reference.com/browse/statistics Generic Pharmaceutical Association. (2008). Industry Statistics. Retrieved September 22‚ 2008‚ from GPhA: http://www.gphaonline.org/Content/NavigationMenu/AboutGenerics/Statistics/default.htm Knowledge@Wharton. (2008‚ April 2). The Use -- and Misuse -- of Statistics:
Premium Food and Drug Administration Statistics Generic drug
Since 2000 the Stock market valuation of the ‘Big Pharma’ companies has dropped sharply. Discuss the causes of the pharmaceutical industry’s current problems and steps that companies are taking to tackle them. By Ali Asgar Kagzi In 1990s‚ pharmaceutical companies were one of the leading shareholder value creators at the stock market. By 1998 the P/E ratio of the Big Pharma companies was twice that of the global stock market and there was a sudden rush among the investors to have a share of
Premium Pharmaceutical industry Pharmacology Drug development
cultural background 4 3) Novartis’ industry: portfolio and mission 5 a) Pharmaceuticals 6 b) Alcon 6 c) Sandoz 6 d) Consumer health 6 e) Vaccines and Diagnostics 7 4) The Novartis’ intercultural characteristics 7 5) The intercultural context of Novartis 7 a) Agreement with the University of California Berkeley - 1998 8 b) Creation of Syngenta – 2000 8 c) Acquisition of Lek Pharmaceuticals – 2002 8 d) Creation of the Novartis Institutes for BioMedical research –
Premium Novartis Pharmaceutical industry Generic drug
Merck & Co.‚ Inc. Recommendation: Buy Target Price Current Price Difference $ 37.09 $ 26.18 41.7%↑ Market Cap. 52 Wk High 52 Wk Low $ 57.48B $ 36.26 $ 25.50 Shrs. Out. 2‚217.6M As of October 21‚ 2005 • Market reaction to Vioxx lawsuits too extreme • Cash flow for company strong enough to absorb potential legal or competitive challenges • Potential blockbuster drugs in the pipeline • A stable of existing drugs to continue driving growth • Aging and growing population
Premium Pharmaceutical industry Pharmacology Food and Drug Administration
Tough on Crime? Pfizer and the CIHR. Healthc Policy [online] 2010 May; 5(4): 16–25. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875889/ [Accessed Oct 26 2012]. Esteban‚ D.‚ 2008. Strengthening corporate social responsibility in the pharmaceutical industry. Journal of Medical Marketing‚ 8(1)‚ pp. 77-79. Kelton‚ E. 2012. Forbes. Big Pharma ’s Offshore Fraud Strategy. [online] Available at: http://www.forbes.com/sites/erikakelton/2012/09/11/big-pharmas-offshore-fraud-strategy/ [Accessed Oct
Premium Business ethics Corporate social responsibility Social responsibility
Subject: Merck‚ the FDA‚ and the Vioxx Recall Facts: Back in 2005‚ Merck was described as a unique force in the pharmaceutical industry; its leadership in profits‚ sales‚ assets‚ and market value was recognized by investors and respected by competitors. Society in general had a favorable reception for the company due to their different acts of generosity‚ like the eternal donation of Mectizan to patients suffering of red blindness. In addition‚ the company has demonstrated high ethical standards
Premium Pharmacology Ethics Clinical trial